サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564658

細胞解析の世界市場の評価：製品・サービス別、用途別、技法別、プロセス別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Cell Analysis Market Assessment, By Product and Service, By Application, By Technique, By Process, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 249 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
細胞解析の世界市場の評価：製品・サービス別、用途別、技法別、プロセス別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
出版日: 2024年10月03日
発行: Market Xcel - Markets and Data
ページ情報: 英文 249 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞解析の市場規模は、2023年の227億817万米ドルから2031年に489億1,348万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで10.07%の成長が見込まれます。市場は、創薬と医薬品開発における細胞解析ツールに対する需要の増加、自動細胞計数、細胞イメージング、フローサイトメトリーなどの先進技術の開発、製薬産業とバイオテクノロジー産業における研究開発活動の急増などにより大きく成長しています。細胞解析市場は、予測期間にさらに成長し、より高い勢いを持つと予測されています。

細胞解析は、細胞の構造、機能、行動のさまざまな側面を特定、測定、研究します。疾患の発見や治療効果の評価にも利用できます。世界の細胞解析市場は、細胞メカニズムの詳細な見識を提供する生物医学研究の発展、有効性と毒性を慎重に評価する創薬開発の支援、疾患マーカーを特定することによる臨床診断の強化に支えられて、さらに成長すると予測されます。

細胞解析市場は、バイオ製薬企業による投資の増加、技術の進歩、個別化医療に対する需要の高まりによってさらに後押しされ、急速な成長を示しています。例えば2024年5月、Eli Lilly and Companyは、インディアナ州とレバノン州の製造施設で生産と製造を拡大するために90億米ドルを投資すると発表しました。これは、さまざまな原薬やパイプライン薬品の製造能力を高めることを目的としています。この進化する部門には、ハイスループットスクリーニング、シングルセル解析、フローサイトメトリー、先進のイメージング技術など多様な技術が含まれます。さらに、創薬は市場の活気を維持する上で重要な役割を果たしています。例えば2024年7月、University of Oxfordとバイオ医薬品のポートフォリオ企業であるApollo Therapeutics Limitedは、University of Oxfordの生物医学研究者によるブレークスルーを翻訳することを目的とした創薬研究開発の共同研究契約を締結したと発表しました。

当レポートでは、世界の細胞解析市場について調査解析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の細胞解析市場の見通し（2017年～2031年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品・サービス別
    • 用途別
    • 技法別
    • プロセス別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
  • 市場マップ分析（2023年）
    • 製品・サービス別
    • 用途別
    • 技法別
    • プロセス別
    • エンドユーザー別
    • 地域別

第5章 北米の細胞解析市場の見通し（2017年～2031年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
  • 製品・サービス別
    • 消耗品、試薬
    • 器具
    • アクセサリ
    • ソフトウェア、サービス
  • 用途別
    • 腫瘍
    • 免疫
    • 心臓
    • 幹細胞
    • 非侵襲性出生前診断
    • その他
  • 技法別
    • フローサイトメトリー
    • 質数量解析
    • 次世代シーケンシング
    • ポリメラーゼ連鎖反応
    • その他
  • プロセス別
    • 細胞識別
    • 標的識別、検証
    • 細胞相互作用
    • 細胞生存率
    • その他
  • エンドユーザー別
    • 学術、研究室
    • 病院、診断検査室
    • 製薬企業
    • その他
  • シェア：国別
  • 各国の市場の評価
    • 米国の細胞解析市場の見通し（2017年～2031年）
    • カナダ
    • メキシコ

第6章 欧州の細胞解析市場の見通し（2017年～2031年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • ポーランド

第7章 アジア太平洋の細胞解析市場の見通し（2017年～2031年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第8章 南米の細胞解析市場の見通し（2017年～2031年）

  • ブラジル
  • アルゼンチン

第9章 中東・アフリカの細胞解析市場の見通し（2017年～2031年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • イスラエル

第10章 需給分析

第11章 輸入と輸出の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

  • 市場促進要因
  • 市場の課題

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

  • 臨床試験
  • 規制当局の承認

第19章 特許情勢

第20章 ケーススタディ

第21章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • Agilent Technologies Inc.
    • Becton, Dickinson and Company
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Merck KGaA
    • Miltenyi Biotec B.V.& Co. KG
    • Olympus Corporation
    • PerkinElmer Inc.
    • Promega Corporation
    • Sysmex Corporation
    • Thermo Fisher Scientific, Inc.

第22章 戦略的推奨

第23章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 3. Global Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 4. Global Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 5. Global Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 6. Global Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Cell Analysis Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 9. North America Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 10. North America Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 12. North America Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 13. North America Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Cell Analysis Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 16. United States Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 17. United States Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 18. United States Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 19. United States Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 20. United States Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 22. Canada Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 23. Canada Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 24. Canada Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 25. Canada Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 26. Canada Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 28. Mexico Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 29. Mexico Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 30. Mexico Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 31. Mexico Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 32. Mexico Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 34. Europe Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 35. Europe Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 36. Europe Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 37. Europe Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 38. Europe Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Cell Analysis Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 41. Germany Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 42. Germany Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 43. Germany Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 44. Germany Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 45. Germany Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 47. France Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 48. France Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 49. France Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 50. France Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 51. France Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Italy Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 54. Italy Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 55. Italy Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 56. Italy Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 57. Italy Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 59. United Kingdom Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 60. United Kingdom Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 61. United Kingdom Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 62. United Kingdom Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 63. United Kingdom Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 65. Russia Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 66. Russia Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 67. Russia Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 68. Russia Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 69. Russia Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 71. Netherlands Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 72. Netherlands Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 73. Netherlands Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 74. Netherlands Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 75. Netherlands Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Spain Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 78. Spain Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 79. Spain Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 80. Spain Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 81. Spain Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Turkey Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 84. Turkey Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 85. Turkey Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 86. Turkey Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 87. Turkey Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Poland Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 90. Poland Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 91. Poland Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 92. Poland Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 93. Poland Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 95. South America Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 96. South America Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 97. South America Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 98. South America Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 99. South America Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Cell Analysis Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 102. Brazil Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 103. Brazil Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 104. Brazil Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 105. Brazil Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 106. Brazil Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 108. Argentina Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 109. Argentina Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 110. Argentina Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 111. Argentina Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 112. Argentina Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 114. Asia-Pacific Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 115. Asia-Pacific Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 116. Asia-Pacific Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 117. Asia-Pacific Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 118. Asia-Pacific Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Cell Analysis Market Share (%), By Country, 2017-2031F
  • Figure 120. India Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 121. India Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 122. India Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 123. India Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 124. India Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 125. India Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 127. China Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 128. China Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 129. China Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 130. China Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 131. China Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Japan Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 134. Japan Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 135. Japan Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 136. Japan Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 137. Japan Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 139. Australia Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 140. Australia Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 141. Australia Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 142. Australia Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 143. Australia Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 145. Vietnam Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 146. Vietnam Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 147. Vietnam Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 148. Vietnam Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 149. Vietnam Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 151. South Korea Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 152. South Korea Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 153. South Korea Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 154. South Korea Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 155. South Korea Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 157. Indonesia Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 158. Indonesia Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 159. Indonesia Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 160. Indonesia Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 161. Indonesia Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 163. Philippines Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 164. Philippines Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 165. Philippines Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 166. Philippines Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 167. Philippines Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Middle East & Africa Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 170. Middle East & Africa Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 171. Middle East & Africa Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 172. Middle East & Africa Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 173. Middle East & Africa Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Cell Analysis Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 176. Saudi Arabia Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 177. Saudi Arabia Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 178. Saudi Arabia Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 179. Saudi Arabia Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 180. Saudi Arabia Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 182. UAE Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 183. UAE Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 184. UAE Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 185. UAE Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 186. UAE Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Cell Analysis Market, By Value, In USD Million, 2017-2031F
  • Figure 188. South Africa Cell Analysis Market Share (%), By Product and Service, 2017-2031F
  • Figure 189. South Africa Cell Analysis Market Share (%), By Application, 2017-2031F
  • Figure 190. South Africa Cell Analysis Market Share (%), By Technique, 2017-2031F
  • Figure 191. South Africa Cell Analysis Market Share (%), By Process, 2017-2031F
  • Figure 192. South Africa Cell Analysis Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product and Service Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195. By Technique Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196. By Process Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 198. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
目次
Product Code: MX12020

Global cell analysis market is projected to witness a CAGR of 10.07% during the forecast period 2024-2031, growing from USD 22,708.17 million in 2023 to USD 48,913.48 million in 2031. The cell analysis market has witnessed significant growth driven by increasing demand for cell analysis tools in drug discovery and development, the development of advanced technologies such as automated cell counting, cell imaging, and flow cytometry, and the surge in R&D activities in the pharmaceutical and biotechnology industry. The cell analysis market is anticipated to thrive further and have a higher momentum during the forecast period.

Cell analysis identifies, measures, and studies different aspects of cell structure, function, and behavior. It can be used to detect disease and evaluate the effectiveness of treatments. The global cell analysis market is expected to grow further, supported by developments in biomedical research that offer detailed insights into cellular mechanisms, supporting drug discovery and development that prudently assess efficacy and toxicity, and enhancing clinical diagnostics by identifying disease markers.

The cell analysis market is experiencing rapid growth, further fueled by rising investments by biopharmaceutical companies, technological advancements, and a heightened demand for personalized medicine. For instance, in May 2024, Eli Lilly and Company announced an investment of USD 9 billion to increase production and manufacturing at their Indiana and Lebanon manufacturing sites. This aims to boost the manufacturing capacity of various APIs and pipeline medicine. This evolving sector includes diverse technologies such as high-throughput screening, single-cell analysis, flow cytometry, and advanced imaging techniques. Furthermore, new drug discovery plays a crucial role in keeping the market vibrant. For instance, in July 2024, the University of Oxford and Apollo Therapeutics Limited, a portfolio biopharmaceutical company, announced the signing of a drug discovery and development collaboration aimed at translating breakthroughs made by biomedical researchers at Oxford.

Increasing Demand for Cell Analysis Tools in Drug Discovery Drives Market Growth

The increasing demand for cell analysis in drug discovery and development drives market growth. Advanced cell screening technologies enhance research by providing precise tools for target drug discovery and validation. These techniques provide accurate data on drug effects and cellular responses, speeding drug development and reducing costs. The search for new therapies drives continued innovation in cellular diagnostic tools. Strategically utilizing advanced cell analysis tools may be effective for enhancing pipeline investments and seizing future market opportunities. For instance, in June 2024, Becton, Dickinson and Company, a leading global medical technology company, announced the commercial launch of a new single-cell research tool to help scientists better understand how the molecular machinery within a cell function and how it regulates changes in a cell that can lead to cancer and other diseases.

Development of Advanced Technologies Positively Impact Market Growth

Technological advancements are significantly boosting growth in the cell analysis market by enhancing research capabilities and broadening application areas. Key developments like high-throughput screening, flow cell measurements, and advanced imaging techniques are at the forefront of this transformation in cell analysis. The market is expanding rapidly as researchers and clinicians seek more accurate, efficient, and scalable solutions for studying cell biology, diagnosing diseases, and developing new treatments. This growth is further fueled by a combination of artificial intelligence and machine learning, which enhance advanced data analysis and interpretation. For instance, in July 2024, Agilent Technologies Inc. launched its novel ProteoAnalyzer system at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT). This system analyzes complex protein mixtures, facilitating quicker discoveries in pharmaceuticals, biopharma, and bioengineered food ingredients.

Prevalence of Oncological Disorders in the Global Cell Analysis Market

With the high prevalence of cancer, there is a substantial need for sophisticated diagnostic tests in the form of liquid biopsies and molecular profiling that are necessary to catch the disease early on with maximum accuracy. This demand drives the development and use of sophisticated cell analysis technologies. global preclinical data in oncology supports the utility of these platforms for evaluating drug efficacy and safety. CRISPR-based approaches, multiplex assays and a gamut of cutting-edge imaging techniques are advancing traditional technologies for cell demographics. These technologies are also applied to the clinic to track disease progression and customize patient care. Initial progress in spatial omics and real-time cellular assays also extends the dimensionality of cell analysis.

For instance, in July 2024, Moffitt Cancer Center received the U.S. FDA approval for lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy, which has shown promising results in treating various types of cancers, particularly melanoma and certain other solid tumors.

North America Dominates the Global Cell Analysis Market

North America holds the largest market share in the global cell analysis market. The region boasts a strong drug discovery ecosystem, quick adoption of cutting-edge technologies, and a high rate of chronic diseases, all of which fuel the demand for advanced cell analysis solutions. Moreover, the rising cases of cancer and substantial investments from both businesses and government organizations in cell-based research also contribute to the growth of the market. For instance, according to the National Cancer Institute, in 2024, an estimated 2 million new cancer cases will be diagnosed in the United States, with 611,720 people expected to die from the disease. By 2040, the number of new cancer cases is projected to rise to 29.9 million annually, and the number of cancer-related deaths is expected to reach 15.3 million.

Future Market Scenario (2024-2031F)

The incorporation of sophisticated fiber optics with microfluidic chips for single-cell analysis is a remarkable progression that will trigger growth in the coming years within this market. This technology improves the accuracy and effectiveness of single-cell research by allowing for direct µ-resolution inspection, images, and evaluation inside the microfluidic device. Thus, it enables the collection of detailed and accurate data about cellular properties within each cell, leading to insight into inter-cellular functions and heterogeneity.

Key Players Landscape and Outlook

The global cell analysis market is quite competitive with a huge number of players at local levels as well. Regulatory approvals of company products, mergers and acquisitions, and collaborations are the most common market strategies that have been observed in recent times.

In September 2023, Agilent Technologies Inc. established a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), to enhance cell and gene therapy over the next three years. This partnership will see the installation and use of Agilent's extelligence real-time cell analyzer, Seahorse XF technology, and additional cell analysis tools at ACTRIS's largest national facility focused on developing and manufacturing cell and gene therapy in Singapore.

In July 2024, Bio-RAD Laboratories, Inc. expanded its Pioneer Antibody Discovery Platform to include rapid generation and screening of bispecific antibodies using its proprietary SpyLock Technology. This enhancement enables customers to efficiently identify and develop effective antibody combinations.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Cell Analysis Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product and Service
      • 4.2.1.1. Consumables and Reagents
      • 4.2.1.2. Instruments
      • 4.2.1.3. Accessories
      • 4.2.1.4. Software and Services
    • 4.2.2. By Application
      • 4.2.2.1. Oncology
      • 4.2.2.2. Immunology
      • 4.2.2.3. Cardiology
      • 4.2.2.4. Stem Cells
      • 4.2.2.5. Non-Invasive Prenatal Diagnosis
      • 4.2.2.6. Others
    • 4.2.3. By Technique
      • 4.2.3.1. Flow Cytometry
      • 4.2.3.2. Mass Spectrometry
      • 4.2.3.3. Next Generation Sequencing
      • 4.2.3.4. Polymerase Chain Reaction
      • 4.2.3.5. Others
    • 4.2.4. By Process
      • 4.2.4.1. Cell Identification
      • 4.2.4.2. Target Identification and Validation
      • 4.2.4.3. Cell Interaction
      • 4.2.4.4. Cell Viability
      • 4.2.4.5. Others
    • 4.2.5. By End-user
      • 4.2.5.1. Academic and Research Laboratories
      • 4.2.5.2. Hospitals and Diagnostic Laboratories
      • 4.2.5.3. Pharmaceutical Companies
      • 4.2.5.4. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia-Pacific
      • 4.2.6.4. South America
      • 4.2.6.5. Middle East and Africa
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product and Service
    • 4.3.2. By Application
    • 4.3.3. By Technique
    • 4.3.4. By Process
    • 4.3.5. By End-user
    • 4.3.6. By Region

5. North America Cell Analysis Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
  • 5.3. By Product and Service
    • 5.3.1. Consumables and Reagents
    • 5.3.2. Instruments
    • 5.3.3. Accessories
    • 5.3.4. Software and Services
  • 5.4. By Application
    • 5.4.1. Oncology
    • 5.4.2. Immunology
    • 5.4.3. Cardiology
    • 5.4.4. Stem Cells
    • 5.4.5. Non-Invasive Prenatal Diagnosis
    • 5.4.6. Others
  • 5.5. By Technique
    • 5.5.1. Flow Cytometry
    • 5.5.2. Mass Spectrometry
    • 5.5.3. Next Generation Sequencing
    • 5.5.4. Polymerase Chain Reaction
    • 5.5.5. Others
  • 5.6. By Process
    • 5.6.1. Cell Identification
    • 5.6.2. Target Identification and Validation
    • 5.6.3. Cell Interaction
    • 5.6.4. Cell Viability
    • 5.6.5. Others
  • 5.7. By End-user
    • 5.7.1. Academic and Research Laboratories
    • 5.7.2. Hospitals and Diagnostic Laboratories
    • 5.7.3. Pharmaceutical Companies
    • 5.7.4. Others
  • 5.8. By Country Share
      • 5.8.1.1. United States
      • 5.8.1.2. Canada
      • 5.8.1.3. Mexico
  • 5.9. Country Market Assessment
    • 5.9.1. United States Cell Analysis Market Outlook, 2017-2031F*
      • 5.9.1.1. Market Size Analysis & Forecast
        • 5.9.1.1.1. By Value
      • 5.9.1.2. Market Share Analysis & Forecast
      • 5.9.1.3. By Product and Service
        • 5.9.1.3.1. Consumables and Reagents
        • 5.9.1.3.2. Instruments
        • 5.9.1.3.3. Accessories
        • 5.9.1.3.4. Software and Services
      • 5.9.1.4. By Application
        • 5.9.1.4.1. Oncology
        • 5.9.1.4.2. Immunology
        • 5.9.1.4.3. Cardiology
        • 5.9.1.4.4. Stem Cells
        • 5.9.1.4.5. Non-Invasive Prenatal Diagnosis
        • 5.9.1.4.6. Others
      • 5.9.1.5. By Technique
        • 5.9.1.5.1. Flow Cytometry
        • 5.9.1.5.2. Mass Spectrometry
        • 5.9.1.5.3. Next Generation Sequencing
        • 5.9.1.5.4. Polymerase Chain Reaction
        • 5.9.1.5.5. Others
      • 5.9.1.6. By Process
        • 5.9.1.6.1. Cell Identification
        • 5.9.1.6.2. Target Identification and Validation
        • 5.9.1.6.3. Cell Interaction
        • 5.9.1.6.4. Cell Viability
        • 5.9.1.6.5. Others
      • 5.9.1.7. By End-user
        • 5.9.1.7.1. Academic and Research Laboratories
        • 5.9.1.7.2. Hospitals and Diagnostic Laboratories
        • 5.9.1.7.3. Pharmaceutical Companies
        • 5.9.1.7.4. Others
    • 5.9.2. Canada
    • 5.9.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Cell Analysis Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Cell Analysis Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Cell Analysis Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Cell Analysis Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Agilent Technologies Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Becton, Dickinson and Company
    • 21.3.3. Bio-RAD Laboratories Inc.
    • 21.3.4. Danaher Corporation
    • 21.3.5. Illumina Inc.
    • 21.3.6. Merck KGaA
    • 21.3.7. Miltenyi Biotec B.V. & Co. KG
    • 21.3.8. Olympus Corporation
    • 21.3.9. PerkinElmer Inc.
    • 21.3.10. Promega Corporation
    • 21.3.11. Sysmex Corporation
    • 21.3.12. Thermo Fisher Scientific, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer